Abiomed's Impella(R) Technology Showcased at TCT 2013 With Over 25 Accepted Presentations in the Scientific Sessions

Published on:

Abiomed Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, notes that there will be over 25 potential Impella presentations in the scientific sessions at the Cardiovascular Research Foundation's (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) 2013 scientific meeting, scheduled from October 27 -- November 1, at the Moscone Convention Center in San Francisco, CA.

On the TCT show floor, Abiomed will conduct daily booth demonstrations at Abiomed booth #1307 and hands-on simulations of the Impella platform.

For further information about the TCT scientific program and the timing of scientific presentations, please contact Aimee Genzler, Corporate Communications Manager, at agenzler@abiomed.com or 978-646-1553.

Related Content

ACR offers resources to achieve radiology AI best practices
PHOTO GALLERY: Examples of FDA-cleared AI in radiology
ACR CEO outlines top trends in breast imaging
Cardiologists partner with imaging AI specialists to improve care for high-risk heart patients
Best in KLAS 2024 rankings released, showcasing medical imaging IT systems
RSNA-sponsored imaging informatics course returns for 2024

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.